Capital World Investors »

Halozyme Therapeutics shares owned by Capital World Investors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Capital World Investors from 13F filings

Historical chart of Capital World Investors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Capital World Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Capital World Investors

Quarter filed Position value Share count Share price at filing
2025-09-30 $61M 832k 73.34
2025-06-30 $41M 782k 52.02
2025-03-31 $48M 748k 63.81
2024-12-31 $36M 748k 47.81